Genomictree Inc. (228760) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.028x

Based on the latest financial reports, Genomictree Inc. (228760) has a cash flow conversion efficiency ratio of -0.028x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-3.21 Billion ≈ $-2.18 Million USD) by net assets (₩115.31 Billion ≈ $78.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Genomictree Inc. fund operations to measure how many days the company can operate on defensive assets alone.

Genomictree Inc. - Cash Flow Conversion Efficiency Trend (2020–2025)

This chart illustrates how Genomictree Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Genomictree Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Genomictree Inc. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
LB Semicon Inc KQ:061970	0.045x
Coca Cola HBC AG LSE:CCH	0.256x
KIP Real Estate Investment Trust KLSE:5280	0.021x
Next PLC LSE:NXT	0.222x
Lucid Diagnostics Inc NASDAQ:LUCD	-1.150x
ANGI Homeservices Inc NASDAQ:ANGI	-0.020x
High Tide Inc NASDAQ:HITI	0.057x
029 GROUP SE INH O.N. XETRA:Z29	N/A

Annual Cash Flow Conversion Efficiency for Genomictree Inc. (2020–2025)

The table below shows the annual cash flow conversion efficiency of Genomictree Inc. from 2020 to 2025. For the full company profile with market capitalisation and key ratios, see Genomictree Inc. stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩115.31 Billion ≈ $78.14 Million	₩-10.19 Billion ≈ $-6.91 Million	-0.088x	+19.40%
2024-12-31	₩124.32 Billion ≈ $84.25 Million	₩-13.63 Billion ≈ $-9.24 Million	-0.110x	-26.02%
2023-12-31	₩125.03 Billion ≈ $84.73 Million	₩-10.88 Billion ≈ $-7.37 Million	-0.087x	-317.38%
2022-12-31	₩107.05 Billion ≈ $72.55 Million	₩4.29 Billion ≈ $2.90 Million	0.040x	+160.38%
2021-12-31	₩115.10 Billion ≈ $78.00 Million	₩-7.63 Billion ≈ $-5.17 Million	-0.066x	+38.01%
2020-12-31	₩95.26 Billion ≈ $64.55 Million	₩-10.19 Billion ≈ $-6.90 Million	-0.107x	--

About Genomictree Inc.

KQ:228760 Korea Biotechnology

Market Cap

$203.12 Million

₩299.73 Billion KRW

Market Cap Rank

#16582 Global

#616 in Korea

Share Price

₩12480.00

Change (1 day)

-4.51%

52-Week Range

₩11120.00 - ₩32000.00

All Time High

₩38550.00